Formestane, a steroidal aromatase inhibitor after failure of non-steroidal aromatase inhibitors (anastrozole and letrozole): Is a clinical benefit still achievable? - Carlini,P.; Frassoldati,A.; De Marco,S.; Casali,A.; Ruggeri,E.M.; Nardi,M. (Ann Oncol, 2001)